Management team to discuss upcoming corporate milestones and review recent developments

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) a developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients, is pleased to announce it will host a special management call to discuss upcoming corporate milestones and review recent developments. The teleconference will be held on Tuesday November 24, 2020 at 1:30 p.m. PT.


The teleconference will be hosted by BevCanna CEO Marcello Leone and CFO John Campbell, and Executive Management Advisor Keith Dolo.

BevCanna is also pleased to announce the debut of its broadcast feature on BNN Bloomberg on Monday November 23, 2020. BevCanna CEO Marcello Leone will be interviewed on BevCanna’s strategy, upcoming launch in the Canadian cannabis market and progress on its international initiatives. BNN Bloomberg reaches more than 982,000 weekly through its national broadcast program and partner sites.

Teleconference Participant Information
To join the call, please use the below dial-in information:
US/Canada (toll-free): 1-800-319-4610
UK (toll-free): 0808-101-2791

Please dial in 5 – 10 min prior to the scheduled start time and simply ask to join the call.

A replay of the call will be available for seven days following the conclusion of the live call. In order to access the replay, dial 1-800-319-6413 (toll-free) and use the passcode 5703# . The Company will also provide a recap of the management teleconference and provide links to the Bloomberg BNN interview.

Webcast Participant Information
To join the call via live streaming, please use the link below:
http://services.choruscall.ca/links/bevcanna20201124.html

About BevCanna Enterprises Inc.

BevCanna Enterprises Inc. (CSE: BEV, OTCQB:BVNNF, FSE:7BC) develops and manufactures cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients. With decades of experience creating, branding and distributing iconic brands that have resonated with consumers on a global scale, the team demonstrates an expertise unmatched in the emerging cannabis beverage category. Based in British Columbia, Canada, BevCanna owns the exclusive rights to a pristine spring water aquifer, access to a world‐class 40,000‐square‐foot, HACCP certified manufacturing facility, with a current bottling capacity of up to 210M bottles per annum. BevCanna also recently acquired U.S. natural health and wellness e-commerce platform Pure Therapy. BevCanna‘s vision is to be a global leader in infused innovations.

On behalf of the Board of Directors:
John Campbell, Chief Financial Officer and Chief Strategy Officer
Director, BevCanna Enterprises Inc.

For media enquiries or interviews, please contact:
Wynn Theriault, Thirty Dash Communications
416‐710‐3370
wynn@thirtydash.ca

For investor inquiries, please contact:
Luca Leone, BevCanna Enterprises Inc.
604‐880‐6618
luca@bevcanna.com

News Provided by Business Wire via QuoteMedia

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced the Company will have senior management participating in the following virtual financial community conferences and events during December 2020 .

  • Roth Deer Valley Consumer Conference – December 9 th to 11 th , 2020
  • Cantor Fitzgerald 2020 Virtual Cannabis MSO Summit – December 15 th to 16 th , 2020
  • MKM Partners – The Road Ahead, Preparation for 2021 Conference – December 15 th to 16 th , 2020

For more information regarding upcoming Curaleaf financial community conference and event participation please visit the investor relations section of the company website, under the events tab, at https://ir.curaleaf.com/events .

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce the appointment of Dr. Joel Moody, MD, MPH, DTM&H, as a medical and clinical advisor to the Company to assist in the expansion of clinical studies in Canada and the clinical data analysis on the ongoing U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19.

“We would like to welcome Dr. Moody as a medical and clinical advisor to our team and we look forward to his contributions in our ongoing FDA Phase 3 clinical study as well as expanding our COVID-19 studies in Canada,” said Michael Frank, CEO of Revive. “Dr. Moody’s experience in clinical epidemiology, data analysis and research are key to our FDA Phase 3 study as we gather clinical data from patients enrolled.”

Keep reading... Show less

– FinCanna Capital Corp. (CSE:CALI) (OTCQB:FNNZF), based in Vancouver, BC today announced that Andriyko Herchak, CEO, will present live at VirtualInvestorConferences.com on December 3 rd .

Keep reading... Show less

First-of-its-kind trial in Canada will pave the way for expanded MDMA-assisted treatment to support patients with posttraumatic stress disorder

Keep reading... Show less

Multi-year partnership designates BioSteel as new official sports drink of Philadelphia 76ers team, Training Complex, and the presenting partner of 76ers Training Camp

BioSteel today announced a multi-year deal with the Philadelphia 76ers, making the sports hydration company the official sports drink of the team. BioSteel will also serve as a partner of the Philadelphia 76ers Training Complex, and the presenting partner for 76ers Training Camp, which begins next week.

Keep reading... Show less